SRSF1 inhibits HBV replication by enhancing the stability of P53 in cell models

LIU Jiajun; LONG Shaoyuan; HU Jieli; CUI Jing

doi:10.16016/j.2097-0927.202503083

您当前的位置：

首页 >

文章列表页 >

SRSF1 inhibits HBV replication by enhancing the stability of P53 in cell models

Basic Medicine | 更新时间：2025-07-14

- SRSF1 inhibits HBV replication by enhancing the stability of P53 in cell models
- Journal of Army Medical University Vol. 47, Issue 13, Pages: 1475-1483(2025)
- 作者机构：
  
  1.重庆医科大学感染性疾病分子生物学教育部重点实验室，重庆
  2.空军军医大学第一附属医院，陕西西安
- 作者简介：
  
  CUI Jing， E-mail： cuijing@cqmu.edu.cn
- 基金信息：
  
  the General Program of National Natural Science Foundation of China(82470634);the Key Scientific and technological Research Project of Chongqing Education Commission(KJZD-K202200409)
- DOI：10.16016/j.2097-0927.202503083
  CLC： R373.21;R394-33;R394.3
- Received：30 March 2025，
  
  Revised：20 May 2025，
  
  Published：15 July 2025
- 稿件说明：
移动端阅览
刘佳俊，龙少媛，胡接力，等.SRSF1通过增加P53的稳定性抑制乙型肝炎病毒复制［J］.陆军军医大学学报，2025，47（13）：1475-1483.DOI：10.16016/j.2097-0927.202503083.

LIU J J，LONG S Y，HU J L，et al.SRSF1 inhibits HBV replication by enhancing the stability of P53 in cell models［J］.J Army Med Univ，2025，47（13）：1475-1483.DOI：10.16016/j.2097-0927.202503083.
刘佳俊，龙少媛，胡接力，等.SRSF1通过增加P53的稳定性抑制乙型肝炎病毒复制［J］.陆军军医大学学报，2025，47（13）：1475-1483.DOI：10.16016/j.2097-0927.202503083. DOI：

LIU J J，LONG S Y，HU J L，et al.SRSF1 inhibits HBV replication by enhancing the stability of P53 in cell models［J］.J Army Med Univ，2025，47（13）：1475-1483.DOI：10.16016/j.2097-0927.202503083. DOI：

摘要

目的

探究丝氨酸/精氨酸富集剪接因子1（serine/arginine-rich splicing factor 1， SRSF1）对乙型肝炎病毒（hepatitis B virus，HBV）复制的影响和机制。

方法

通过Southern blot、Northern blot、ELISA实验在不同的HBV复制细胞模型中检测SRSF1对HBV复制的影响；通过荧光定量PCR实验、荧光素酶报告系统以及ChIP实验在HepG2细胞中研究SRSF1对HBV核心启动子/增强子活性的影响。利用Western blot和泛素化检测实验探索SRSF1与P53的关系，同时在不同的HBV复制细胞模型中验证P53对HBV复制的影响，之后明确P53在SRSF1抑制HBV中的作用。

结果

过表达SRSF1可以在多种HBV复制细胞模型中显著抑制HBV DNA和HBV RNA，降低HBeAg和HBsAg的分泌水平（

0.000 1）。SRSF1还可以抑制HBV核心启动子活性，尽管这种抑制是通过间接机制调控的。此外，SRSF1通过保护P53免受泛素化和随后的蛋白酶体降解从而增强P53的稳定性。同时，过表达P53或敲低P53对HBV的调控作用也在不同的细胞模型中得到了验证（

0.000 1）。

结论

剪接因子SRSF1的过表达可以显著抑制HBV的复制，且该抑制效应在多种肝癌细胞模型中均有重现性，这一抑制效应由其增强P53的稳定性来介导。

Abstract

Objective‍　‍To investigate the effect and underlying mechanism of serine and arginine rich splicing factor 1 (SRSF1) on the replication of hepatitis B virus (HBV). Methods‍　‍The effects of SRSF1 on HBV replication were investigated in different HBV replicating cell models by Southern blotting

Northern blotting and ELISA. Quantitative PCR

luciferase reporter assay and chromatin immunoprecipitation (ChIP) were applied to dete

rmine the effects of SRSF1 on the activities of HBV core promoter/enhancer in HepG2 cells. The relationship between SRSF1 and P53 was explored with Western blotting and ubiquitination assay. The effects of P53 on HBV replication were verified in different HBV replicating cell models

and the role of P53 in SRSF1 inhibition of HBV was clarified. Results‍　‍Overexpression of SRSF1 significantly inhibited HBV DNA and HBV RNA and reduced HBsAg and HBeAg secretion levels in a variety of HBV replicative cell models (

0.0001). SRSF1 also inhibited the activity of HBV core promoter

although this inhibition was regulated by indirect mechanisms. In addition

SRSF1 enhanced P53 stability by protecting P53 from ubiquitination and subsequent proteasomal degradation. Meanwhile

the regulatory effect of overexpression or knockdown of P53 on HBV was validated in different cell models (

0.0001). Conclusion‍　‍Overexpression of splicing factor SRSF1 significantly inhibits HBV replication in a variety of cell models

and this inhibitory effect is mediated by its enhancement of P53 stability.

关键词

Keywords

references

JIANG Y ， HAN Q J ， ZHAO H J ， et al . The mechanisms of HBV-induced hepatocellular carcinoma ［J］. J Hepatocell Carcinoma ， 2021 ， 8 ： 435 - 450 . DOI： 10.2147/JHC.S307962 http://dx.doi.org/10.2147/JHC.S307962 .

胡接力，黄爱龙 . 乙型肝炎病毒cccDNA动力学的思维框架［J］. 中华肝脏病杂志， 2023 ， 31 （ 5 ）： 545 - 550 . DOI： 10.3760/cma.j.cn501113-20230330-00134 http://dx.doi.org/10.3760/cma.j.cn501113-20230330-00134 .

HU J L ， HUANG A L . A conceptual framework for dynamics of cccDNA in hepatitis B virus ［J］， Chin. J. Hepatol， 2023 ， 31 （ 5 ）： 545 - 550 . DOI： 10.3760/cma.j.cn501113-20230330-00134 http://dx.doi.org/10.3760/cma.j.cn501113-20230330-00134 .

GEHRING A ， BERTOLETTI A ， TAVIS J E . Host factor-targeted hepatitis B virus therapies ［J］. Intervirology ， 2014 ， 57 （ 3/4 ）： 158 - 162 . DOI： 10.1159/000360938 http://dx.doi.org/10.1159/000360938 .

CRISPINO J D ， BLENCOWE B J ， SHARP P A . Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP ［J］. Science ， 1994 ， 265 （ 5180 ）： 1866 - 1869 . DOI： 10.1126/science.8091213 http://dx.doi.org/10.1126/science.8091213 .

DAS S ， KRAINER A R . Emerging functions of SRSF1， splicing factor and oncoprotein， in RNA metabolism and cancer ［J］. Mol Cancer Res ， 2014 ， 12 （ 9 ）： 1195 - 1204 . DOI： 10.1158/1541-7786.MCR-14-0131 http://dx.doi.org/10.1158/1541-7786.MCR-14-0131 .

CÁCERES J F ， MISTELI T ， SCREATON G R ， et al . Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity ［J］. J Cell Biol ， 1997 ， 138 （ 2 ）： 225 - 238 . DOI： 10.1083/jcb.138.2.225 http://dx.doi.org/10.1083/jcb.138.2.225 .

DAS S ， ANCZUKÓW O ， AKERMAN M ， et al . Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC ［J］. Cell Rep ， 2012 ， 1 （ 2 ）： 110 - 117 . DOI： 10.1016/j.celrep.2011.12.001 http://dx.doi.org/10.1016/j.celrep.2011.12.001 .

KARNI R ， DE STANCHINA E ， LOWE S W ， et al . The gene encoding the splicing factor SF 2 /ASF is a proto-oncogene ［J］. Nat Struct Mol Biol ， 2007 ， 14 （ 3 ）： 185 - 193 . DOI： 10.1038/nsmb1209 http://dx.doi.org/10.1038/nsmb1209 .

GOUT S ， BRAMBILLA E ， BOUDRIA A ， et al . Abnormal expression of the pre-mRNA splicing regulators SRSF1， SRSF2， SRPK1 and SRPK2 in non small cell lung carcinoma ［J］. PLoS One ， 2012 ， 7 （ 10 ）： e46539 . DOI： 10.1371/journal.pone.0046539 http://dx.doi.org/10.1371/journal.pone.0046539 .

FENG Z G ， KE S J ， WANG C Q ， et al . RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway ［J］. Oncogene ， 2023 ， 42 （ 24 ）： 2017 - 2030 . DOI： 10.1038/s41388-023-02710-w http://dx.doi.org/10.1038/s41388-023-02710-w .

GUO L ， LIU J J ， LONG S Y ， et al . TIM22 and TIM29 inhibit HBV replication by up-regulating SRSF1 expression ［J］. J Med Virol ， 2024 ， 96 （ 2 ）： e29439 . DOI： 10.1002/jmv.29439 http://dx.doi.org/10.1002/jmv.29439 .

NASSAL M . The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly ［J］. J Virol ， 1992 ， 66 （ 7 ）： 4107 - 4116 . DOI： 10.1128/JVI.66.7.4107-4116.1992 http://dx.doi.org/10.1128/JVI.66.7.4107-4116.1992 .

FAN S Y ， LONG S Y ， LIU J J ， et al . Nicotinamide N-methyltransferase inhibits HBV replication by suppressing NR5A1 expression invitro ［J］. Biochem Biophys Res Commun ， 2022 ， 614 ： 70 - 77 . DOI： 10.1016/j.bbrc.2022. 04.122 http://dx.doi.org/10.1016/j.bbrc.2022.04.122 .

LEFEVRE P ， MELNIK S ， WILSON N ， et al . Developmentally regulated recruitment of transcription factors and chromatin modification activities to chicken lysozyme Cis-regulatory elements in vivo ［J］. Mol Cell Biol ， 2003 ， 23 （ 12 ）： 4386 - 4400 . DOI： 10.1128/mcb.23.12.4386-4400.2003 http://dx.doi.org/10.1128/mcb.23.12.4386-4400.2003 .

FREGOSO O I ， DAS S ， AKERMAN M ， et al . Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence ［J］. Mol Cell ， 2013 ， 50 （ 1 ）： 56 - 66 . DOI： 10.1016/j.molcel.2013.02.001 http://dx.doi.org/10.1016/j.molcel.2013.02.001 .

KATSUYAMA T ， LI H ， COMTE D ， et al . Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity ［J］. J Clin Invest ， 2019 ， 129 （ 12 ）： 5411 - 5423 . DOI： 10.1172/JCI127949 http://dx.doi.org/10.1172/JCI127949 .

JUAREZ I ， SU S ， HERBERT Z T ， et al . Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunity ［J］. Front Immunol ， 2022 ， 13 ： 906355 . DOI： 10.3389/fimmu.2022.906355 http://dx.doi.org/10.3389/fimmu.2022.906355 .

KATSUYAMA T ， MOULTON V R . Splicing factor SRSF1 is indispensable for regulatory T cell homeostasis and function ［J］. Cell Rep ， 2021 ， 36 （ 1 ）： 109339 . DOI： 10.1016/j.celrep.2021.109339 http://dx.doi.org/10.1016/j.celrep.2021.109339 .

VENABLES J P . Aberrant and alternative splicing in cancer ［J］. Cancer Res ， 2004 ， 64 （ 21 ）： 7647 - 7654 . DOI： 10.1158/0008-5472.CAN-04-1910 http://dx.doi.org/10.1158/0008-5472.CAN-04-1910 .

SATO Y ， TSURUMI T . Genome guardian p53 and viral infections ［J］. Rev Med Virol ， 2013 ， 23 （ 4 ）： 213 - 220 . DOI： 10.1002/rmv.1738 http://dx.doi.org/10.1002/rmv.1738 .

QIAN L Y ， FAN H X ， JU Y ， et al . A peptide-based inhibitor of gp96 suppresses HBsAg expression and HBV replication by upregulation of p53 ［J］. J Gen Virol ， 2019 ， 100 （ 8 ）： 1241 - 1252 . DOI： 10.1099/jgv.0.001289 http://dx.doi.org/10.1099/jgv.0.001289 .

ORI A ， ZAUBERMAN A ， DOITSH G ， et al . p53 binds and represses the HBV enhancer： an adjacent enhancer element can reverse the transcription effect of p53 ［J］. EMBO J ， 1998 ， 17 （ 2 ）： 544 - 553 . DOI： 10.1093/emboj/17.2.544 http://dx.doi.org/10.1093/emboj/17.2.544 .

YAN Y ， ALLWEISS L ， YANG D L ， et al . Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection ［J］. Emerg Microbes Infect ， 2019 ， 8 （ 1 ）： 879 - 894 . DOI： 10.1080/22221751.2019.1625728 http://dx.doi.org/10.1080/22221751.2019.1625728 .

JEONG Y ， HAN J ， JANG K L . Reactive oxygen species induction by hepatitis B virus： implications for viral replication in p53-positive human hepatoma cells ［J］. Int J Mol Sci ， 2024 ， 25 （ 12 ）： 6606 . DOI： 10.3390/ijms25126606 http://dx.doi.org/10.3390/ijms25126606 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Rapamycin-induced autophagy promotes HBV replication

Dynamic analysis of serum markers of HBV in 302 infants of pregnant women with HBV infection

Construction of transgenic vector pBR002-HLA-DRB1*0803 and its expression and antigen-presenting function

Correlation of HPV16E6 with p53 in oral cancer

Fibronectin extra domain A suppresses apoptosis of colorectal cancer SW480 cells by inhibiting P53 nuclear translocation

Related Author

Li Xia

Huang Wenjuan

Zhu Sufei

Chen Weixian

WANG Jing

ZHU Yan

LIU Zhongwei

LIU Huimin

Related Institution

Department of Laboratory Medicine, Second Affiliated Hospital, Chongqing Medical University

Institute of Infectious Diseases, Chongqing Key Laboratory of Infectious Diseases Research, First Affiliated Hospital, Army Medical University (Third Military Medical University)

第三军医大学：西南医院全军感染病研究所，感染病研究重庆市重点实验室，基础医学部实验动物学教研室

Department of Prosthodontics, Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering at Colleges and Universities, 3Department of Maxillofacial Surgery, Stomatological Hospital of Chongqing Medical University

Department of Oncology, Southwest Hospital, Third Military Medical University

⁰